sec filing
GR
NASDAQ · GRCE
Grace Therapeutics, Inc.
Healthcare · Biotechnology
$1.81
Down-$0.03 (-1.63%)
Updated Nov 5, 2026, 2:18 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 47.49M
- P/E ratio
- -6.84
- Dividend yield
- 0.00%
- 52-week range
- $1.67 – $5.18
- Volume
- 64.64K
- Avg. volume
- 65.65K
Price performance · GRCE
GRCE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
GRCE closed at $1.81 after 21 trading sessions, down 13.81% for the selected period.
- Last close
- $1.81
- Period change
- -13.81%
- Period low
- $1.81
- Period high
- $2.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $1.849 | $1.96 | $1.78 | $1.81 | 64.64K |
| Nov 3, 2026 | $1.80 | $2.01 | $1.70 | $1.84 | 231.1K |
| Nov 2, 2026 | $1.93 | $1.95 | $1.76 | $1.81 | 99.54K |
| Oct 30, 2026 | $1.95 | $1.9799 | $1.87 | $1.94 | 85.94K |
| Oct 29, 2026 | $1.99 | $2.0478 | $1.882 | $1.94 | 75.99K |
| Oct 28, 2026 | $1.87 | $2.03 | $1.87 | $2.01 | 164.69K |
| Oct 27, 2026 | $1.80 | $1.90 | $1.80 | $1.87 | 110.54K |
| Oct 26, 2026 | $1.94 | $1.99 | $1.67 | $1.81 | 487.8K |
| Oct 23, 2026 | $1.91 | $1.95 | $1.88 | $1.93 | 47.22K |
| Oct 22, 2026 | $1.91 | $1.93 | $1.87 | $1.915 | 97.1K |
| Oct 21, 2026 | $1.96 | $2.02 | $1.94 | $1.97 | 77.14K |
| Oct 20, 2026 | $1.90 | $2.07 | $1.89 | $1.98 | 94.41K |
| Oct 19, 2026 | $1.89 | $1.97 | $1.8216 | $1.88 | 90.43K |
| Oct 16, 2026 | $1.9701 | $2.0305 | $1.85 | $1.89 | 168.8K |
| Oct 15, 2026 | $1.91 | $1.97 | $1.89 | $1.95 | 109.29K |
| Oct 14, 2026 | $1.97 | $2.01 | $1.8461 | $1.89 | 177.97K |
| Oct 13, 2026 | $2.00 | $2.02 | $1.965 | $1.99 | 53.84K |
| Oct 12, 2026 | $2.02 | $2.06 | $1.98 | $2.02 | 50.63K |
| Oct 9, 2026 | $2.05 | $2.09 | $2.03 | $2.08 | 37.79K |
| Oct 8, 2026 | $2.05 | $2.07 | $2.00 | $2.04 | 52.59K |
| Oct 7, 2026 | $2.06 | $2.12 | $2.05 | $2.10 | 84.25K |
Latest GRCE news
The latest Smart Investors Daily articles mentioning GRCE.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…